Ukraine’s Foreign Minister Says “Nothing Changes” After Russian Annexations, Ukraine Will Continue Liberating Occupied Territories

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE: MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD).